A Role for Mitochondrial Bak in Apoptotic Response to Anticancer Drugs
Open Access
- 1 September 2001
- journal article
- Published by Elsevier BV in Journal of Biological Chemistry
- Vol. 276 (36), 34307-34317
- https://doi.org/10.1074/jbc.m103526200
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- Proapoptotic BAX and BAK: A Requisite Gateway to Mitochondrial Dysfunction and DeathScience, 2001
- Bid-induced Cytochrome c Release Is Mediated by a Pathway Independent of Mitochondrial Permeability Transition Pore and BaxJournal of Biological Chemistry, 2000
- Cytochrome c Deficiency Causes Embryonic Lethality and Attenuates Stress-Induced ApoptosisCell, 2000
- Different expression patterns of Bcl-2 family genes in breast cancer by estrogen receptor status with special reference to pro-apoptotic Bak geneCell Death & Differentiation, 2000
- Bax and Adenine Nucleotide Translocator Cooperate in the Mitochondrial Control of ApoptosisScience, 1998
- BAX frameshift mutations in cell lines derived from human haemopoietic malignancies are associated with resistance to apoptosis and microsatellite instabilityOncogene, 1998
- The Release of Cytochrome c from Mitochondria: A Primary Site for Bcl-2 Regulation of ApoptosisScience, 1997
- Modulation of apoptosis by the widely distributed Bcl-2 homologue BakNature, 1995
- Cloning of a bcl-2 homologue by interaction with adenovirus E1B 19KNature, 1995
- Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programed cell deathCell, 1993